Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Form 8.5 (EPT/RI) - Amendment

28 Dec 2018 11:03

RNS Number : 7144L
Citigroup Global Markets Limited
28 December 2018
Β 

Β 

Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Shire plc

(d) Date dealing undertaken:

21 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

YESTakeda Pharmaceutical Company Limited

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ADR

Purchase

11,903

USDΒ 171.5000

USDΒ 169.7100

ADR

Sale

11,203

USDΒ 171.5000

USDΒ 169.7100

5p ordinary

Purchase

1,385,721

USDΒ 57.8352

USDΒ 56.8522

5p ordinary

Purchase

1,576,795

GBPΒ 45.8500

GBPΒ 44.6250

5p ordinary

Sale

2,597,025

GBPΒ 45.3050

GBPΒ 44.6250

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

5p ordinary

TRS

Closing Short Position

350

GBPΒ 45.0426

5p ordinary

TRS

Closing Short Position

27,322

GBPΒ 45.0426

5p ordinary

TRS

Closing Short Position

1,926

GBPΒ 45.0426

5p ordinary

TRS

Opening Long Position

250,000

GBPΒ 45.1800

5p ordinary

TRS

Closing Long Position

76

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

155

GBPΒ 45.0750

5p ordinary

TRS

Closing Short Position

200

GBPΒ 45.0700

5p ordinary

TRS

Closing Short Position

14,017

GBPΒ 45.0713

5p ordinary

TRS

Closing Short Position

53

GBPΒ 45.0900

5p ordinary

TRS

Closing Short Position

200

GBPΒ 45.0700

5p ordinary

TRS

Closing Short Position

200

GBPΒ 45.0650

5p ordinary

TRS

Closing Short Position

200

GBPΒ 45.0700

5p ordinary

TRS

Closing Short Position

155

GBPΒ 45.0650

5p ordinary

TRS

Closing Short Position

6,280

GBPΒ 45.0717

5p ordinary

TRS

Closing Short Position

4,678

GBPΒ 45.0682

5p ordinary

TRS

Closing Short Position

29

GBPΒ 45.0650

5p ordinary

TRS

Closing Short Position

521,944

GBPΒ 44.8992

5p ordinary

TRS

Closing Short Position

48

GBPΒ 45.0750

5p ordinary

TRS

Closing Short Position

13

GBPΒ 45.0600

5p ordinary

TRS

Closing Short Position

10

GBPΒ 45.0750

5p ordinary

TRS

Increasing Short Position

818

GBPΒ 44.8950

5p ordinary

TRS

Increasing Long Position

173

GBPΒ 45.3050

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2600

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2750

5p ordinary

TRS

Increasing Long Position

178

GBPΒ 45.2600

5p ordinary

TRS

Increasing Long Position

30

GBPΒ 45.2850

5p ordinary

TRS

Increasing Long Position

176

GBPΒ 45.2850

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2750

5p ordinary

TRS

Increasing Long Position

1

GBPΒ 45.3050

5p ordinary

TRS

Increasing Long Position

35

GBPΒ 45.3000

5p ordinary

TRS

Increasing Long Position

178

GBPΒ 45.2900

5p ordinary

TRS

Increasing Long Position

178

GBPΒ 45.2700

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2900

5p ordinary

TRS

Increasing Long Position

422

GBPΒ 45.3028

5p ordinary

TRS

Increasing Long Position

148

GBPΒ 45.2800

5p ordinary

TRS

Increasing Long Position

90

GBPΒ 45.2700

5p ordinary

TRS

Reducing Long Position

265

GBPΒ 44.8950

5p ordinary

TRS

Increasing Long Position

177

GBPΒ 45.2950

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2600

5p ordinary

TRS

Increasing Long Position

179

GBPΒ 45.2600

5p ordinary

TRS

Increasing Long Position

51

GBPΒ 45.2750

5p ordinary

TRS

Increasing Long Position

887

GBPΒ 45.2886

5p ordinary

TRS

Increasing Long Position

183

GBPΒ 45.2550

5p ordinary

TRS

Increasing Long Position

440

GBPΒ 45.2901

5p ordinary

TRS

Closing Short Position

5,063

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

499

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

8,212

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

473,731

GBPΒ 44.8950

5p ordinary

TRS

Increasing Long Position

105

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

40

GBPΒ 45.2500

5p ordinary

TRS

Increasing Short Position

200,000

USDΒ 57.8352

5p ordinary

TRS

Increasing Short Position

140,000

USDΒ 57.0235

5p ordinary

TRS

Increasing Short Position

182,905

USDΒ 56.8522

5p ordinary

TRS

Increasing Short Position

595,950

USDΒ 56.9544

5p ordinary

TRS

Increasing Short Position

47,676

USDΒ 56.8522

5p ordinary

TRS

Closing Short Position

15,328

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

52,297

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

930

GBPΒ 44.8950

5p ordinary

TRS

Closing Short Position

9,665

GBPΒ 44.8950

5p ordinary

TRS

Increasing Short Position

100,000

USD 56.8808

5p ordinary

TRS

Increasing Short Position

119,190

USD 57.3242

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Typee.g. American,European etc.

Expiry date

Option money paid/ received per unit

Β 

Β 

(ii) Exercise

Β 

Β 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Β 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

Β 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

Β 

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Date of disclosure:

28 December 2018

Contact name:

Damian Flanagan

Telephone number:

028 90409676

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
FEREAFAPAEAPFFF
Date   Source Headline
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:12 amRNSForm 8.5 (EPT/RI)
7th Jan 20199:40 amRNSForm 8.5 (EPT/RI)
7th Jan 20199:39 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20199:33 amRNSForm 8.3 - Shire PLC
7th Jan 20197:00 amRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20197:00 amRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20197:00 amRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20197:00 amRNSForm 8.5 (EPT/RI) - Amendment
4th Jan 20193:20 pmRNSForm 8.3 - Shire plc
4th Jan 20193:15 pmRNSForm 8.5 (EPT/NON-RI)
4th Jan 20193:07 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
4th Jan 20193:06 pmRNSForm 8.3 - Shire plc
4th Jan 20193:00 pmRNSForm 8.3 - Shire plc
4th Jan 20192:59 pmRNSForm 8.5 (EPT/NON-RI)
4th Jan 20192:53 pmRNSForm 8.5 (EPT/RI) - Amendment
4th Jan 20192:49 pmRNSForm 8.3 - Shire plc
4th Jan 20192:26 pmBUSForm 8.3 - Shire plc
4th Jan 20192:16 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
4th Jan 20192:14 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
4th Jan 20192:11 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
4th Jan 20191:33 pmBUSForm 8.3 - SHIRE PLC
4th Jan 20191:32 pmBUSForm 8.3 - SHIRE PLC AMENDMENT
4th Jan 201911:13 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
4th Jan 201911:04 amRNSForm 8.3 - Shire plc
4th Jan 201910:36 amRNSForm 8.5 (EPT/RI)
4th Jan 201910:29 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Jan 201910:27 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Jan 201910:27 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
4th Jan 201910:17 amRNSForm 8.5 (EPT/RI)- Shire plc
4th Jan 20199:58 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
4th Jan 20199:49 amRNSForm 8.5 (EPT/RI)
4th Jan 20199:29 amRNSForm 8.3 - Shire PLC
3rd Jan 20195:59 pmBUSForm 8.3 - Shire plc
3rd Jan 20193:44 pmBUSForm 8.3 - SHIRE PLC
3rd Jan 20193:32 pmBUSForm 8.3 - Shire plc
3rd Jan 20193:20 pmBUSForm 8.3 - Shire PLC
3rd Jan 20193:00 pmRNSForm 8.3 - Shire plc
3rd Jan 20193:00 pmRNSForm 8.3 - Shire plc
3rd Jan 20193:00 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Jan 20192:37 pmRNSForm 8.5 (EPT/NON-RI)
3rd Jan 20192:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Jan 20192:27 pmRNSForm 8.3 - Shire plc
3rd Jan 20192:17 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
3rd Jan 20192:16 pmRNSForm 8.3 - Shire plc
3rd Jan 20192:14 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
3rd Jan 20192:14 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
3rd Jan 20192:12 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
3rd Jan 20192:10 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.